Fate Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
12278 Scripps Summit Dr, San Diego, Cali...Phone Number
(858) 875-1800Website
www.fatetherapeutics.comRevenue
$6.5 MillionStock Symbol
FATEIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
2
2
1
About Fate Therapeutics
Fate Therapeutics, established and headquartered in San Diego, California, is a clinical-stage biopharmaceutical company focused on developing innovative cellular immunotherapies. The company specializes in research and development of treatments for cancer and immune disorders, utilizing advanced cellular technology to create therapeutic solutions. As a publicly traded organization, Fate Therapeutics continues to advance its pipeline of cellular immunotherapy products through various clinical trials, working to address significant unmet medical needs in oncology and immunology.Explore more
Fate Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fate Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Fate Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Fate Therapeutics
Earning: See what the market has to say on Fate Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Fate Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Fate Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Fate Therapeutics has new funding data
Check out if Fate Therapeutics is spiking on competitors!
Fate Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Fate Therapeutics
Compare insights from companies similar to Fate Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fate Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Fate Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Fate Therapeutics.
Fate Therapeutics financials insights
Gather financial insights about Fate Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$40.4M
2014
Debt
$20M
2015
Stock Offering
$32M
2016
Share Placement
$10.3M
Share Placement
$57M
2017
Stock Offering
$42.9M
2018
Grant
$4M
Stock Offering
$143.8M
2019
Stock Offering
$173.1M
Fate Therapeutics Tech Stack
A closer look at the technologies used by Fate Therapeutics
See more technologies
Most Recent Scoops
Person-Based
Bob Valamehr highlighting its potential as an accessible CAR T-cell therapy for autoimmune diseases.
Bioengineering, Medical Research, Pharmaceuticals, Accessibility
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Medical Research, Clinical Operations
Person-Based
Person-Based
Bioengineering
Fate Therapeutics News & Media
Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference
SAN DIEGO, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in a fireside chat at the 2026 Annual Cantor Global Healthcare Conference, being held September 9–12, 2026 in New York, NY. Discussion topics will incluFate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial of FT819 for the Treatment of Lupus Nephritis
First patient dosed in an outpatient setting, discharged the same day; multiple patients in the process of screening at several activated sitesFate Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
First lupus nephritis patient dosed in RECLAIM-LN, a Phase 2 potentially registrational trial utilizing FT819, an iPSC-derived, off-the-shelf CAR T-cell therapy; patient was treated as an outpatient with same-day dischargeFate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies broadly to patients with cancer and autoimmune diseases, today announced that on August 1, 2026, the Company granted (i) non-qualified stock options to one newly-hired non-executive employee to purchase a total of 37,300 shares of the Company’s common
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Fate Therapeutics
Sign Up For FreeTo access detailed company insights
Fate Therapeutics, established and headquartered in San Diego, California, is a clinical-stage biopharmaceutical company focused on developing innovative cellular immunotherapies. The company specializes in research and development of treatments for cancer and immune disorders, utilizing advanced cellular technology to create therapeutic solutions.... Read More
